Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||
| Net Income | -7,121 | -3,785 | -18,090 |
| Depreciation Amortization | 10 | 5 | 20 |
| Accounts payable and accrued liabilities | 1,488 | 577 | N/A |
| Other Working Capital | 372 | 39 | -3,520 |
| Other Operating Activity | -1,352 | -533 | 4,470 |
| Operating Cash Flow | $-6,604 | $-3,697 | $-17,120 |
| Cash Flows From Investing Activities | |||
| PPE Investments | N/A | N/A | -7 |
| Other Investing Activity | 0 | 0 | 5,847 |
| Investing Cash Flow | $0 | $N/A | $5,840 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 0 | 0 | 19,020 |
| Financing Cash Flow | $0 | $0 | $19,020 |
| Beginning Cash Position | 7,895 | 7,895 | 150 |
| End Cash Position | 1,291 | 4,198 | 7,890 |
| Net Cash Flow | $-6,604 | $-3,697 | $7,740 |
| Free Cash Flow | |||
| Operating Cash Flow | -6,604 | -3,697 | -17,120 |
| Free Cash Flow | -6,604 | -3,697 | -17,120 |